Literature DB >> 30981560

A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease.

Li-Wei Chen1, Pin-Ren Huang2, Cheng-Hung Chien3, Chih-Lang Lin4, Rong-Nan Chien5.   

Abstract

BACKGROUND/
PURPOSE: Nonalcoholic fatty liver disease (NAFLD) is now a global liver disease. The fatty liver index (FLI), which is calculated by the equation comprising waist circumference, body mass index (BMI), triglyceride, and gamma glutamyl transpeptidase (GGT), is frequently used for hepatic steatosis evaluation. This study aimed to evaluate the optimal cut-off point of FLI to select subjects for abdominal ultrasonography (US) screening for NAFLD in the community.
METHODS: From August 2013 to August 2016, a community-based study was performed in the northeastern region of Taiwan. All subjects participated in a demographic survey, blood testing, and abdominal US. The formula for FLI is: FLI = [e 0.953×loge (TG)+0.139×BMI+0.718×loge (GGT) +0.053×waist circumference-15.745]/[1 + e 0.953×loge (TG)+0.139×BMI+0.718×loge (GGT)+0.053×waist circumference-15.745] × 100.
RESULTS: A total of 1371 subjects were included (746 in NAFLD group and 625 in the control group). The mean ages were 57.1 years in the control group and 56.3 years in the NAFLD group. The optimal cut-off points of FLI to discriminate fatty liver by abdominal US were 20 in male and 10 in female (sensitivity 80.3% and 76.1%; specificity 66.9% and 65.5%, respectively). FLI was correlated with the severity of fatty liver by abdominal US, predict fat component percent and NAFLD fibrosis score, especially in the female subjects.
CONCLUSION: FLI could be a tool to select subjects for abdominal US in a large community survey. The cut-off point of FLI might be set to 10 for female and 20 for male subjects, to increase the sensitivity for selecting subjects to receive abdominal US.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Fatty liver; Non-alcoholic fatty liver disease; Ultrasonography

Mesh:

Substances:

Year:  2019        PMID: 30981560     DOI: 10.1016/j.jfma.2019.03.016

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  9 in total

1.  Fatty Liver Index Independently Predicts All-Cause Mortality in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis but No Substantial Liver Disease.

Authors:  Pil Gyu Park; Jung Yoon Pyo; Sung Soo Ahn; Hyun Joon Choi; Jason Jungsik Song; Yong-Beom Park; Ji Hye Huh; Sang-Won Lee
Journal:  Front Cardiovasc Med       Date:  2022-06-23

2.  Fatty Liver Index and Skeletal Muscle Density.

Authors:  Julie A Pasco; Sophia X Sui; Emma C West; Kara B Anderson; Pamela Rufus-Membere; Monica C Tembo; Natalie K Hyde; Lana J Williams; Zoe S J Liu; Mark A Kotowicz
Journal:  Calcif Tissue Int       Date:  2022-01-13       Impact factor: 4.000

3.  Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees.

Authors:  Kenichiro Murayama; Michiaki Okada; Kenichi Tanaka; Chika Inadomi; Wataru Yoshioka; Yoshihito Kubotsu; Tomomi Yada; Hiroshi Isoda; Takuya Kuwashiro; Satoshi Oeda; Takumi Akiyama; Noriko Oza; Hideyuki Hyogo; Masafumi Ono; Takumi Kawaguchi; Takuji Torimura; Keizo Anzai; Yuichiro Eguchi; Hirokazu Takahashi
Journal:  Diagnostics (Basel)       Date:  2021-01-16

4.  Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis.

Authors:  Marco Castellana; Rossella Donghia; Vito Guerra; Filippo Procino; Luisa Lampignano; Fabio Castellana; Roberta Zupo; Rodolfo Sardone; Giovanni De Pergola; Francesco Romanelli; Pierpaolo Trimboli; Gianluigi Giannelli
Journal:  J Clin Med       Date:  2021-04-26       Impact factor: 4.241

5.  A fluorine-18 labeled radiotracer for PET imaging of γ-glutamyltranspeptidase in living subjects.

Authors:  Dingyao Gao; Yinxing Miao; Siqin Ye; Chunmei Lu; Gaochao Lv; Ke Li; Chunjing Yu; Jianguo Lin; Ling Qiu
Journal:  RSC Adv       Date:  2021-05-24       Impact factor: 4.036

6.  Improving the accuracy of fatty liver index to reflect liver fat content with predictive regression modelling.

Authors:  Hykoush A Asaturyan; Nicolas Basty; Marjola Thanaj; Brandon Whitcher; E Louise Thomas; Jimmy D Bell
Journal:  PLoS One       Date:  2022-09-13       Impact factor: 3.752

7.  The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.

Authors:  Haofei Hu; Yong Han; Changchun Cao; Yongcheng He
Journal:  J Transl Med       Date:  2022-09-05       Impact factor: 8.440

8.  Fatty liver index as a predictor of increased risk of cardiometabolic disease: finding from the Kuopio Ischaemic Heart Disease Risk Factor Study Cohort.

Authors:  Olubunmi O Olubamwo; Jyrki K Virtanen; Jussi Pihlajamaki; Pekka Mantyselka; Tomi-Pekka Tuomainen
Journal:  BMJ Open       Date:  2019-09-05       Impact factor: 2.692

9.  Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population.

Authors:  Eun-Ju Cho; Gu-Cheol Jung; Min-Sun Kwak; Jong-In Yang; Jeong-Yoon Yim; Su-Jong Yu; Goh-Eun Chung
Journal:  Diagnostics (Basel)       Date:  2021-11-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.